Voisard Asset Management Group, Inc. Editas Medicine, Inc. Transaction History
Voisard Asset Management Group, Inc.
- $240 Billion
- Q3 2024
A detailed history of Voisard Asset Management Group, Inc. transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Voisard Asset Management Group, Inc. holds 100 shares of EDIT stock, worth $138. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100
Previous 100
-0.0%
Holding current value
$138
Previous $467,000
26.98%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding EDIT
# of Institutions
250Shares Held
56.9MCall Options Held
410KPut Options Held
394K-
Black Rock Inc. New York, NY7.78MShares$10.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.68MShares$9.22 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$6.76 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$4.62 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$3.4 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $94.9M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...